Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_assertion description "[Diabetes increased cardiac PRR (prorenin receptor) expression and nuclear translocation of PLZF (promyelocytic zinc finger protein), which was completely prevented by aliskiren and valsartan, and partially by benazeprilat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_assertion evidence source_evidence_literature NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_assertion SIO_000772 23116220 NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_assertion wasDerivedFrom befree-2016 NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_assertion wasGeneratedBy ECO_0000203 NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1025300.RAm_v5wlu3rY_4GZ1tqhH--3acQhKnpvvW7cUSEIsMyx8130_provenance.